Physician profile
Luke S Won
NPI 1144625823
$574.13
in general payments reported to CMS, 2019-2025
11 companies · $21.50 in 2025
The $21.50 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $126 · 2020: $140 · 2021: $233 · 2022: $53.78 · 2025: $21.50.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $21.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $21.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nestle Healthcare Nutrition INC. | $149.44 | 2021-2022 | |
| Avanir Pharmaceuticals, INC. | $125.59 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $83.08 | 2021 | |
| Stryker Corporation | $56.59 | 2020 | |
| Janssen Pharmaceuticals, INC | $36.77 | 2021 | |
| Glaxosmithkline, LLC. | $29.21 | 2020 | |
| Corcept Therapeutics | $21.50 | 2025 | Korlym |
| Amarin Pharma, INC. | $20.63 | 2020 | |
| Fidia Pharma USA INC. | $18.75 | 2020 | |
| Abbvie INC. | $17.98 | 2021 | |
| Allergan, INC. | $14.59 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luke Won listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.